2014 Annual Meeting | 4NF.001 - Neuro Flash: Epilepsy

Date Tuesday 04/29/14

Time 06:30 AM - 08:00 AM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Neuro Flash

Director(s) Cynthia L. Harden, MD

Topic(s)

Learning Objectives Participants should be able to discuss with patients the evidence for marijuana risks and benefits in epilepsy; advise women with epilepsy on the appropriate contraception, based on their individual antiepileptic treatment; employ a treatment algorithm when catamenial seizure exacerbations are present; counsel women and families regarding the risk of autism with in utero valproate exposure; and understand the surgical options for medically intractable epilepsy patients, including emerging, less invasive approaches.

CME Available No CME available

Recommended Audience Trainee, General Neurologist, Specialist Neurologist

Teaching Styles Case-based, Didactic, Interactive, Audience Participation

Event Timeline
06:30 AM - 07:00 AM		Marijuana and Epilepsy: What Is the Evidence? David Gloss, MD, FAAN
07:00 AM - 07:30 AM		Three Cs of Caring for Women with Epilepsy: Contraception, Catamenial Seizures, and Cognitive Teratogenesis Cynthia L. Harden, MD
07:30 AM - 08:00 AM		Epilepsy Surgery: Less Pain, More Gain—Moving Toward Minimally Invasive Techniques

Faculty Disclosures
Cynthia L. Harden, MD	Dr. Harden has received personal compensation for serving as an employee of Xenon Pharmaceuticals Inc.. Dr. Harden has stock in Xenon Pharmaceuticals Inc.. Dr. Harden has received intellectual property interests from a discovery or technology relating to health care.
David Gloss, MD, FAAN	Dr. Gloss has received personal compensation in the range of $500-$4,999 for serving as a DUR Board Member with WV Dept of Health and Human Services.